JW Lifescience Corporation

Informe acción KOSE:A234080

Capitalización de mercado: ₩169.9b

Salud financiera de hoja de balance de JW Lifescience

Salud financiera controles de criterios 6/6

JW Lifescience tiene un patrimonio de accionistas total de ₩159.4B y una deuda total de ₩46.2B, lo que sitúa su ratio deuda-patrimonio en 29%. Sus activos y pasivos totales son ₩255.8B y ₩96.4B respectivamente. El BAIT de JW Lifescience es de ₩30.9B, por lo que su ratio de cobertura de intereses es de 19.7. Tiene efectivo e inversiones a corto plazo que ascienden a ₩28.3B.

Información clave

28.3%

Ratio deuda-patrimonio

₩46.18b

Deuda

Ratio de cobertura de intereses28.3x
Efectivo₩34.53b
Patrimonio₩163.44b
Total pasivo₩96.95b
Activos totales₩260.39b

Actualizaciones recientes sobre salud financiera

Recent updates

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Apr 20
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

Mar 11
Introducing JW Lifescience (KRX:234080), A Stock That Climbed 36% In The Last Year

What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Feb 21
What Type Of Shareholders Make Up JW Lifescience Corporation's (KRX:234080) Share Registry?

Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

Feb 02
Is JW Lifescience Corporation (KRX:234080) A Smart Pick For Income Investors?

We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Jan 12
We Think JW Lifescience (KRX:234080) Can Manage Its Debt With Ease

Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Dec 23
Is It Smart To Buy JW Lifescience Corporation (KRX:234080) Before It Goes Ex-Dividend?

Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

Dec 23
Is JW Lifescience Corporation's (KRX:234080) Recent Performance Tethered To Its Attractive Financial Prospects?

How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

Nov 27
How Much Did JW Lifescience's(KRX:234080) Shareholders Earn From Share Price Movements Over The Last Three Years?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₩107.8B) de A234080 superan a sus pasivos a corto plazo (₩94.3B).

Pasivo a largo plazo: Los activos a corto plazo de A234080 (₩107.8B) superan a sus pasivos a largo plazo (₩2.2B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (11.2%) de A234080 se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de A234080 ha pasado de 50.4% a 29% en los últimos 5 años.

Cobertura de la deuda: La deuda de A234080 está bien cubierta por el flujo de caja operativo (81.3%).

Cobertura de intereses: Los pagos de intereses de la deuda de A234080 están bien cubiertos por el BAIT (19.7x cobertura).


Hoja de balance


Descubre empresas con salud financiera